deconex dmx

Generic: dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride

Labeler: poly pharmaceuticals, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name deconex dmx
Generic Name dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride
Labeler poly pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

dextromethorphan hydrobromide 17.5 mg/1, guaifenesin 400 mg/1, phenylephrine hydrochloride 10 mg/1

Manufacturer
Poly Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 50991-740
Product ID 50991-740_1cda4e52-f3cb-04b3-e063-6394a90a863f
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2019-06-01

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50991740
Hyphenated Format 50991-740

Supplemental Identifiers

RxCUI
2172190
UNII
9D2RTI9KYH 495W7451VQ 04JA59TNSJ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deconex dmx (source: ndc)
Generic Name dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 17.5 mg/1
  • 400 mg/1
  • 10 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (50991-740-01)
  • 12 BLISTER PACK in 1 CARTON (50991-740-02) / 1 TABLET in 1 BLISTER PACK
source: ndc

Packages (2)

50991-740-01 100 TABLET in 1 BOTTLE (50991-740-01) 50991-740-02 12 BLISTER PACK in 1 CARTON (50991-740-02) / 1 TABLET in 1 BLISTER PACK

Ingredients (3)

dextromethorphan hydrobromide (17.5 mg/1) guaifenesin (400 mg/1) phenylephrine hydrochloride (10 mg/1)

Linked Drug Pages (1)

DECONEX DMX ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1cda4e52-f3cb-04b3-e063-6394a90a863f", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["2172190"], "spl_set_id": ["8aab8e5c-1633-2e5a-e053-2a95a90adcc5"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Poly Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50991-740-01)", "package_ndc": "50991-740-01", "marketing_start_date": "20190601"}, {"sample": false, "description": "12 BLISTER PACK in 1 CARTON (50991-740-02)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "50991-740-02", "marketing_start_date": "20190601"}], "brand_name": "DECONEX DMX", "product_id": "50991-740_1cda4e52-f3cb-04b3-e063-6394a90a863f", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "50991-740", "generic_name": "Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride", "labeler_name": "Poly Pharmaceuticals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "DECONEX", "brand_name_suffix": "DMX", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "17.5 mg/1"}, {"name": "GUAIFENESIN", "strength": "400 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190601", "listing_expiration_date": "20261231"}